Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Dementia and Cognitive Improvement

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Donepezil 10 mg/day vs placebo

Quality of life of participants (change from baseline at 26 weeks) · people with Alzheimer's disease

1 finding from 1 review

Donepezil for dementia due to Alzheimer's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 815 participants
Moderate

Rivastigmine vs placebo

Quality of life of patients or carers (measured using NPI‐D carer distress scale (change from baseline at 24 weeks) · Apathy in people with mild‐to‐moderate Alzheimer's disease

1 finding from 1 review

Rivastigmine for Alzheimer's disease 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 529 participants
Moderate